Skip to content

Advanced Diffusion Tensor MRI for Breast Cancer

Advanced Diffusion Tensor MRI for Breast Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04774471
Enrollment
68
Registered
2021-03-01
Start date
2021-02-03
Completion date
2023-05-18
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Diseases

Keywords

Diffusion Tensor Imaging, MRI

Brief summary

The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.

Detailed description

The goal of this study is to answer the question: what is the ability of the BIT-Motion (Breast Imaging Tensor-Motion) software to detect and discriminate between benign and malignant breast lesions that are identified on mammogram (MG) and ultrasound (US) examinations. Women over the age of 18 who have a breast lesion that is seen on MG or US will be eligible to enroll. Participation in this study will involve one non-invasive non-contrast MRI scan of the breasts.

Interventions

DIAGNOSTIC_TESTEvaluation of BIT-Motion software

Software program to discern benign versus malignant breast lesions.

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female * scheduled for ultrasound or stereotactic guided breast biopsy * \> 18 years of age * able to tolerate up to 90 minutes in the MRI scanner

Exclusion criteria

* Male * Has a medical condition that, in the opinion of the investigator, puts the subject at significant risk * Has any contraindication to the MRI examination as determined by standard NorthShore University Health System relative to MRI safety * Cannot comprehend or complete the Informed Consent Form

Design outcomes

Primary

MeasureTime frameDescription
Pathologic diagnosisOne monthMRI scans evaluated with BIT-Motion software will be compared to definitive pathologic diagnosis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026